Vaccine Willingness and Impact of the COVID-19 Pandemic on Women's Perinatal Experiences and Practices-A Multinational, Cross-Sectional Study Covering the First Wave of the Pandemic.

COVID-19 SARS-CoV-2 breastfeeding community health services counseling maternity care pregnancy primary health care public health vaccine hesitancy

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
24 03 2021
Historique:
received: 29 01 2021
revised: 11 03 2021
accepted: 22 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 10 4 2021
Statut: epublish

Résumé

The COVID-19 pandemic may be of particular concern for pregnant and breastfeeding women. We aimed to explore their beliefs about the coronavirus and COVID-19 vaccine willingness and to assess the impact of the pandemic on perinatal experiences and practices. A multinational, cross-sectional, web-based study was performed in six European countries between April and July 2020. The anonymous survey was promoted via social media. In total, 16,063 women participated (including 6661 pregnant and 9402 breastfeeding women). Most responses were collected from Belgium (44%), Norway (18%) and the Netherlands (16%), followed by Switzerland (11%), Ireland (10%) and the UK (3%). Despite differences between countries, COVID-19 vaccine hesitancy was identified among 40-50% of the respondents at the end of the first wave of the pandemic and was higher among pregnant women. Education level and employment status were associated with vaccine hesitancy. The first wave had an adverse impact on pregnancy experiences and disrupted access to health services and breastfeeding support for many women. In the future, access to health care and support should be maintained at all times. Evidence-based and tailored information on COVID-19 vaccines should also be provided to pregnant and breastfeeding women to avoid unfounded concerns about the vaccines and to support shared decision making in this population.

Identifiants

pubmed: 33805097
pii: ijerph18073367
doi: 10.3390/ijerph18073367
pmc: PMC8038007
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Curr Pharm Des. 2019;25(5):469-482
pubmed: 30907309
Int J Gynaecol Obstet. 2020 Oct;151(1):146-147
pubmed: 32620037
J Affect Disord. 2020 Dec 1;277:5-13
pubmed: 32777604
N Engl J Med. 2020 Oct 1;383(14):1296-1299
pubmed: 32589371
Eur J Epidemiol. 2021 Feb;36(2):197-211
pubmed: 33649879
Matern Child Nutr. 2021 Jan;17(1):e13088
pubmed: 32969184
Matern Child Health J. 2021 Jan;25(1):15-21
pubmed: 33244678
Int J Environ Res Public Health. 2020 Sep 17;17(18):
pubmed: 32957434
MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1641-1647
pubmed: 33151921
JAMA Netw Open. 2020 Sep 1;3(9):e2019686
pubmed: 32876685
JAMA Netw Open. 2020 Nov 2;3(11):e2029256
pubmed: 33211113
J Gynecol Obstet Hum Reprod. 2020 Sep;49(7):101826
pubmed: 32505805
Am J Obstet Gynecol. 2021 Jan 15;:
pubmed: 33460584
Emerg Microbes Infect. 2020 Dec;9(1):1467-1469
pubmed: 32552365
Ann Pharmacother. 2010 Sep;44(9):1478-84
pubmed: 20736425
Eur J Clin Pharmacol. 2019 Jul;75(7):995-1003
pubmed: 30834472
Lancet. 2020 Nov 21;396(10263):1614-1616
pubmed: 33159850
Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:490-501
pubmed: 32795828
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Int J Clin Pharm. 2016 Aug;38(4):968-76
pubmed: 27241342
Reprod Health. 2021 Jan 18;18(1):10
pubmed: 33461593
JAMA. 2021 Mar 16;325(11):1039-1040
pubmed: 33555297
Midwifery. 2020 Sep;88:102779
pubmed: 32600862
J Am Med Inform Assoc. 2020 Jul 1;27(7):1132-1135
pubmed: 32324855
JAMA. 2020 Dec 29;:
pubmed: 33372943
Lancet. 2020 Sep 26;396(10255):898-908
pubmed: 32919524
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Appetite. 2021 Jan 1;156:104985
pubmed: 33038477
Lancet. 2021 Feb 13;397(10274):578
pubmed: 33549167
BMJ. 2020 Sep 1;370:m3320
pubmed: 32873575
Vaccine. 2015 Nov 25;33(47):6420-9
pubmed: 26320417
Am J Obstet Gynecol. 2021 Jan;224(1):35-53.e3
pubmed: 32739398
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Obstet Gynecol. 2021 Mar 1;137(3):408-414
pubmed: 33370015
Acta Obstet Gynecol Scand. 2020 Jul;99(7):819-822
pubmed: 32386441
JAMA. 2020 Oct 6;324(13):1347-1348
pubmed: 32822495
Acta Obstet Gynecol Scand. 2021 Jan 21;:
pubmed: 33475148

Auteurs

Michael Ceulemans (M)

Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
Teratology Information Service, Pharmacovigilance Centre Lareb, 5237 MH 's Hertogenbosch, The Netherlands.

Veerle Foulon (V)

Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.

Alice Panchaud (A)

Service of Pharmacy, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland.

Ursula Winterfeld (U)

Swiss Teratogen Information Service, Service de Pharmacologie Clinique, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.

Léo Pomar (L)

Materno-Fetal and Obstetrics Research Unit, Lausanne University Hospital, 1011 Lausanne, Switzerland.

Valentine Lambelet (V)

Materno-Fetal and Obstetrics Research Unit, Lausanne University Hospital, 1011 Lausanne, Switzerland.

Brian Cleary (B)

Rotunda Hospital, D01 P5W9 Dublin, Ireland.
School of Pharmacy, Royal College of Surgeons Ireland, D02 VN51 Dublin, Ireland.

Fergal O'Shaughnessy (F)

Rotunda Hospital, D01 P5W9 Dublin, Ireland.
School of Pharmacy, Royal College of Surgeons Ireland, D02 VN51 Dublin, Ireland.

Anneke Passier (A)

Teratology Information Service, Pharmacovigilance Centre Lareb, 5237 MH 's Hertogenbosch, The Netherlands.

Jonathan Luke Richardson (JL)

UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE2 4AB, UK.

Karel Allegaert (K)

Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
Woman and Child, Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
Department of Clinical Pharmacy, Erasmus MC Sophia Children's Hospital, 3000 CA Rotterdam, The Netherlands.

Hedvig Nordeng (H)

Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.
Department of Child Health and Development, Norwegian Institute of Public Health, 0213 Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH